Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin Visit us on Tiktok

Choose Your Language:

Welcome Dr. Ho Jin Kim!

Posted by: The Sumaira Foundation in News & Announcements

November 8, 2024 — The Sumaira Foundation is pleased to welcome Dr. Ho Jin Kim of the National Cancer Center in South Korea to join TSF’s international Medical Advisory Board. Dr. Kim joins TSF as the first NMOSD/MOGAD expert from South Korea to join our growing team.

Ho Jin Kim, MD, PhD

Dr. Ho Jin Kim serves as the Head of the Department of Neurology at the National Cancer Center, Korea, concurrently holding a professorship at the National Cancer Center Graduate School of Cancer Science & Policy.

He obtained his medical degree, as well as a master’s degree and doctorate, from Seoul National University, where he also completed his residency in neurology, along with clinical fellowships in multiple sclerosis and neuromuscular disease. Dr. Kim furthered his academic pursuits as a research fellow in neuroimmunology at the University of Southern California, USA. Then he spent four years as a senior fellow and staff researcher in MS and neuroimmunology at the Montreal Neurological Institute of McGill University, Canada. His primary research focus centers on autoimmune inflammatory diseases of the CNS, encompassing multiple sclerosis, neuromyelitis optica spectrum disorder, and MOG antibody associated disease.

Dr. Kim has authored over 250 peer-reviewed articles in esteemed academic journals. Presently, he holds the position of vice-president at PACTRIMS and of president at the Korean Society of Neuroimmunology. Additionally, he serves as a co-editor for the Multiple Sclerosis Journal and an associate editor for the Journal of Clinical Neurology.


Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.